Effectiveness of Ixekizumab in Elderly Patients for the Treatment of Moderate-to-Severe Psoriasis: Results From a Multicenter, Retrospective Real-Life Study in the Lazio Region

• Egile Nagusiak: Annunziata Dattola (Egilea), Nicoletta Bernardini (Egilea), Giacomo Caldarola (Egilea), Rosa Coppola (Egilea), Clara De Simone (Egilea), Domenico Giordano (Egilea), Alessandro Giunta (Egilea), Gaia Moretta (Egilea), Gianluca Pagnanelli (Egilea), Vincenzo Panasiti (Egilea), Severino Persechino (Egilea), Concetta Potenza (Egilea), Federica Trovato (Egilea), Arianna Zangrilli (Egilea), Luca Bianchi (Egilea), Giovanni Pellacani (Egilea), Ketty Peris (Egilea), Antonio Giovanni Richetta (Egilea)
• Formatua: Liburua
• Argitaratua: Mattioli1885, 2024-07-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Introduction: This was an observational, retrospective, multicenter study, enrolling elderly patients (>65 years old) treated with ixekizumab with a diagnosis of psoriasis (PsO) and/or psoriatic arthritis (PsA) during the period 2020 to 2023. Objectives: We sought to investigate the efficacy of i...